Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1996
DOI: 10.1002/(sici)1096-911x(199607)27:1<8::aid-mpo3>3.0.co;2-k
|View full text |Cite
|
Sign up to set email alerts
|

Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A Childrens Cancer Group study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
47
1
1

Year Published

1997
1997
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 141 publications
(51 citation statements)
references
References 13 publications
2
47
1
1
Order By: Relevance
“…7) However, most studies question the effect of chemotherapy. 4,14) Chemotherapy failed to improve the outcome in children with ependymoma. 4) In our case, the tumor arose in the supratentorial cerebral hemisphere and was anaplastic ependymoma (WHO grade III), which matches the previously reported characteristics.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…7) However, most studies question the effect of chemotherapy. 4,14) Chemotherapy failed to improve the outcome in children with ependymoma. 4) In our case, the tumor arose in the supratentorial cerebral hemisphere and was anaplastic ependymoma (WHO grade III), which matches the previously reported characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…3) There are numerous prognostic factors such as resection extent, radiation strategy, chemotherapy, histological grade, location, and so on. [3][4][5][6]10,11,14,15,18) As can be expected, high grade anaplastic ependymoma carries a poorer prognosis than low grade.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…41 Multiple agents including carboplatin, cisplatin, etoposide, idarubicin, ifosfamide, irinotecan, carmustine, and TMZ have been studied in phase II trials with modest response. 162 Multi-agent strategies (e.g., lomustine, prednisone, and vincristine), 163 as well as high-dose chemotherapy with stem cell rescue have been disappointing and can not be generally recommended. 164 Chemotherapy to date is used as an adjuvant therapy in patients with residual or recurrent disease, but cannot be recommended as standard treatment.…”
Section: Chemotherapymentioning
confidence: 99%
“…Chemotherapy has been used in an effort to delay irradiation and hopefully improve outcome in young children. A North American Childrens Cancer Group randomized trial in the 1980s (CCG-942) that evaluated adjuvant chemotherapy with lomustine, vincristine, and prednisone after surgery and irradiation failed to show any difference in OS when compared to irradiation alone; craniospinal irradiation (36Gy) with primary site boost (54 Gy) was administered to all patients [20]. The studies undertaken to delay chemotherapy in young children have generally shown poor success rates [9,[21][22][23].…”
Section: Discussionmentioning
confidence: 99%